These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2905752)

  • 21. [Urinary gamma-glutamyl transpeptidase as an index of renal tubular lesions during controlled hypotension produced by sodium nitroprusside].
    Ruz Ortiz A; Sancho Ruiz H; Muñoz Benítez R; Ruiz Fernández de Mesa L; Galán Cabezas A; Alemany Esteban F; Lluch Fernández M
    Rev Esp Anestesiol Reanim; 1987; 34(4):255-9. PubMed ID: 2889245
    [No Abstract]   [Full Text] [Related]  

  • 22. Phosphate metabolism in renal stone formers. (I): Indices of phosphate handling in calcium stone patients and healthy subjects.
    Wikström B; Backman U; Danielson BG; Fellström B; Hellsing K; Johansson G; Ljunghall S
    Scand J Urol Nephrol Suppl; 1981; 61():I:1-18. PubMed ID: 6947410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal tubular dysfunctions in patients with idiopathic calcium nephrolithiasis.
    Pabico RC; McKenna BA; Freeman RB
    Miner Electrolyte Metab; 1987; 13(6):462-8. PubMed ID: 3696099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal tubular defects in recurring bilateral nephrolithiasis.
    D'Angelo A; Pagano F; Ossi E; Lupo A; Valvo E; Messa P; Tessitore N; Maschio G
    Clin Nephrol; 1976 Aug; 6(2):352-60. PubMed ID: 954242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New pathophysiologic aspects of nephrolithiasis].
    Hess B
    Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis.
    Böhles H; Gebhardt B; Beeg T; Sewell AC; Solem E; Posselt G
    J Pediatr; 2002 Jan; 140(1):103-9. PubMed ID: 11815772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the physicochemical risk for renal stone disease during pregnancy.
    Smith CL; Kristensen C; Davis M; Abraham PA
    Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
    Monga M; Macias B; Groppo E; Kostelec M; Hargens A
    J Urol; 2006 Jul; 176(1):127-31. PubMed ID: 16753386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of preoperative administration of isoptin on the blood flow and function of the kidneys in patients with nephrolithiasis].
    Karaev ME; Samedov RN; Vezirov MS; Kaliaev ShM
    Vestn Khir Im I I Grek; 1988 Dec; 141(12):74-7. PubMed ID: 3250071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Active and recurrent kidney calculi. Metabolic findings and therapeutic consequences].
    Jorgensen H; Quist Paulsen A; Berstad A; Harbitz TB
    Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1551-5. PubMed ID: 929531
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Leaving no (renal) stone unturned.
    Raisz LG
    N Engl J Med; 1975 Mar; 292(10):528-9. PubMed ID: 163961
    [No Abstract]   [Full Text] [Related]  

  • 32. Tubular dysfunction in nephrolithiasis: a consequence of the stone.
    Jaeger P; Portmann L; Ginalski JM; Burckhardt P
    Contrib Nephrol; 1987; 58():122-6. PubMed ID: 3691115
    [No Abstract]   [Full Text] [Related]  

  • 33. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.
    Subha K; Varalakshmi P
    Biochem Mol Biol Int; 1993 Feb; 29(2):271-80. PubMed ID: 7684293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in phosphorus clearance determined by the administration of glucose in diseases of the parathyroids and in other pathological conditions.
    Martini PF; Piancino G; Modica A
    Acta Endocrinol (Copenh); 1967 Apr; 54(4):629-36. PubMed ID: 6071485
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.
    Kovacevic L; Lu H; Caruso JA; Lakshmanan Y
    Urology; 2016 Jun; 92():100-5. PubMed ID: 26892647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal tubular function in normal pregnancy.
    Noble MC; Landon MJ; Davison JM
    Br J Obstet Gynaecol; 1978 Aug; 85(8):638-40. PubMed ID: 28743
    [No Abstract]   [Full Text] [Related]  

  • 38. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
    Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
    Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The significance of citrate, uromucoid and GAG for diagnosis of renal tubular acidosis in patients with urinary calculi].
    Bichler KH; Henzler B; Strohmaier WL; Stahl C; Korn S
    Urologe A; 1995 Nov; 34(6):437-43. PubMed ID: 8848853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.